REGN vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

REGN
REGENERON PHARMACEUTICALS, INC.
A
80%
Confidence
VS
MSFT
MICROSOFT CORP
A
91%
Confidence

REGN vs MSFT Fundamental Comparison

Metric REGN MSFT
Revenue $3.6B $241.8B
Net Income $727.2M $98.0B
Net Margin 20.2% 40.5%
ROE 2.3% 23.6%
ROA 1.8% 14.1%
Current Ratio 3.57x 1.28x
Debt/Equity 0.06x 0.10x
EPS $6.75 $13.14

Green = Better metric | Red = Weaker metric

View Full REGN Analysis →
View Full MSFT Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Top Rated Undervalued Growth Dividend

You Might Also Compare

REGN vs AAPL MSFT vs GOOGL REGN vs AMZN MSFT vs NVDA

REGN vs MSFT: Frequently Asked Questions

Is REGN or MSFT the better stock in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. REGN is graded A (80% confidence) while MSFT is graded A (91% confidence). This is not investment advice.

How does REGN compare to MSFT fundamentally?

REGENERON PHARMACEUTICALS, INC. has ROE of 2.3% vs MICROSOFT CORP's 23.6%. Net margins are 20.2% vs 40.5% respectively.

Which stock pays higher dividends, REGN or MSFT?

REGN has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in REGN or MSFT for long term?

For long-term investing, consider that REGN has a A grade with 80% confidence, while MSFT has a A grade with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about REGN vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.